We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
EBQ:The ADJUST-PE Study
From WikEM
(Redirected from EBQ:ADJUST-PE Trial)
Under Review Journal Club Article
Righini M, Van Es J,Den Exter PL, et al.. "Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism". JAMA. 2014. 311(11):1117-1124.
PubMed Full text
PubMed Full text
Contents
Clinical Question
Is an age-adjusted D-dimer cutoff (age × 10 in patients >50 yrs) associated with an increased diagnostic yield of D-dimer in elderly patients with suspected PE?
Conclusion
An age-adjusted D-dimer in combination with pretest probability was associated with a larger number of patients in whom PE could be considered ruled out with a low likelihood of subsequent clinical venous thromboembolism.
Major Points
- An age-adjusted D-dimer is associated with a greater number of patients in whom PE can be safely ruled out
Study Design
A multicenter, multinational, prospective management outcome study in 19 centers in Belgium, France, the Netherlands, and Switzerland between January 1, 2010, and February 28, 2013.
Population
Patient Demographics
- Women: 56.8%
- Age: median 63 yrs (53-74 1st/3rd quartile)
- H/O VTE: 14.0%
- Active malignancy: 12.9%
- Surgery within 1 month: 11.8%
- Estrogen use: 5.5%
- Chest pain: 48.3%
- Dyspnea: 62.9%
- Syncope: 7.9%
- Hemoptysis: 4.1%
- Heart rate: mean 87.1 beats/min
- Respiratory rate: mean 19.2 breaths/min
Inclusion Criteria
- Clinical suspicion of PE
- Acute onset SOB
- Worsening SOB
- Chest pain without obvious etiology
Exclusion Criteria
- PE suspicion raised more than 24 hrs after admission
- Taking anticoagulant therapy
- Inability to receive a CTPA study
- Life expectancy <3 mos
- Ongoing pregnancy
- Unable to follow up
Interventions
- Risk assessed with revised Geneva score or Wells
- Highly sensitive D-dimer measurement
- CTPA
- Participants with a D-dimer value between the conventional cutoff of 500 μg/L and their age-adjusted cutoff did not undergo CTPA and were left untreated and formally followed-up for a 3-month period
Outcomes
Primary Outcome
- Failure rate of the diagnostic strategy
- Conventional 500 μg/L cut off lead to 1 nonfatal PE in 810 patients (0.1% [0.0%-0.7%])
- Age-adjusted cut off lead to 1 nonfatal PE in 331 patients (0.3% [0.1%-1.7%])
Secondary Outcomes
- Proportion of patients with a low-intermediate probability and a D-dimer between 500 μg/L and their age-adjusted cutoff
value
- Age-adjusted cutoff resulted in an 11.6% absolute increase [10.5%-12.9%] or a 41.2% relative increase [31.3%-52.0%] in the proportion of negative D-dimer results
Subgroup analysis
- Elderly patients, defined as patients 75 years or older
- None of the 195 patients had a confirmed VTE during follow-up (0.0% [95% CI, 0.0%-1.9%])
Discussion
Criticisms & Further Discussion
- The assays used had a cutoff of 500 ug/L; take caution in applying age x 10 until you know your hospitals assay
- R.E.B.E.L EM
- 2 different pretest probability scores and 6 different d-dimer assays were used
- Not a randomized clinical control study, so there was no control group
- 7 patients were deceased in the > 500 ug/L and < age adjusted cutoff d-dimer, but only one had an autopsy to confirm diagnosis, therefore hard to exclude PE as the cause of death
- Prevalence of PE was higher than what is cited in most North American studies, but the same rate as European studies
- Patient follow up was not with the gold standard CTPA
External Links
R.E.B.E.L EM: Age-Adjusted D-dimer
Funding
- Swiss National Research Foundation grant 32003B-130863
- International Society on Thrombosis and Haemostasis 2007 presidential fund
- Dutch Thrombosis Foundation grant 2010-5
- Projets Hospitaliers de Recherche Clinique, French Ministry of Health grant PHRC 2011 08-01
- France, the study was sponsored by Direction de la Recherche Clinique et de l’Innovation, Brest University Hospital